Edition:
United Kingdom

Insider Trading: BioXcel Therapeutics Inc (BTAI.OQ)

BTAI.OQ on NASDAQ Stock Exchange Capital Market

10.44USD
13 Sep 2019
Change (% chg)

$-0.03 (-0.29%)
Prev Close
$10.47
Open
$10.49
Day's High
$10.75
Day's Low
$10.21
Volume
6,044
Avg. Vol
13,122
52-wk High
$11.94
52-wk Low
$2.41

All Insider Trades
Trading Date Name Title Type Shares Traded Price
23 Aug 2019

Mueller (Peter)

Director Buy 1,554 $9.34
22 Aug 2019

Mueller (Peter)

Director Buy 6,646 $8.83
21 Aug 2019

Mueller (Peter)

Director Buy 1,800 $8.42
16 Aug 2019

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 974 $8.89
15 Aug 2019

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 2,625 $8.67
14 Aug 2019

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 358 $8.44
13 Aug 2019

Yocca (Frank D. Ph.D.)

Officer Buy 6,547 $8.67
13 Aug 2019

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 1,000 $8.75
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 200 $4.32
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 800 $4.27
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 100 $4.50
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 400 $4.49
14 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 500 $4.48
7 Dec 2018

Mueller (Peter)

Director Buy 6,905 $5.01
7 Dec 2018

Mueller (Peter)

Director Buy 495 $5.00
6 Dec 2018

Mueller (Peter)

Director Buy 1,295 $5.00
6 Dec 2018

Mueller (Peter)

Director Buy 100 $5.01
4 Dec 2018

Mueller (Peter)

Director Buy 1,076 $5.09
4 Dec 2018

Mueller (Peter)

Director Buy 325 $5.11
4 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 500 $5.09
4 Dec 2018

Mueller (Peter)

Director Buy 2,062 $5.15
4 Dec 2018

Mehta (Vimal Ph.D.)

Chief Executive Officer Buy 500 $5.15
4 Dec 2018

Mueller (Peter)

Director Buy 200 $5.13
4 Dec 2018

Yocca (Frank D. Ph.D.)

Officer Buy 450 $5.20
4 Dec 2018

Mueller (Peter)

Director Buy 344 $5.12

Institutional Holders

% Shares Owned: 24.20%
# of Holders: 55
Total Shares Held: 3,807,594
3 Mo. Net Change: 488,174
# New Positions: 31
# Closed Positions: 2
# Increased Positions: 41
# Reduced Positions: 9
# Net Buyers: 32

Officers & Directors

Name Age Since Current Position

Peter Mueller

61 2017 Independent Chairman of the Board

Vimal Mehta

57 2017 President, Chief Executive Officer, Secretary, Director

Richard Steinhart

61 2017 Chief Financial Officer

Frank Yocca

62 2017 Chief Scientific Officer

Chids Mahadevan

46 2017 Vice President - Finance

Luca Rastelli

50 2017 Vice President - Oncology R&D

Robert Risinger

2019 Vice President Clinical Development

Vikas Sharma

2018 Vice President - Business Development

Vincent O'Neill

2017 Chief Medical Officer

Krishnan Nandabalan

55 2017 Director

Sandeep Laumas

51 2017 Independent Director

Michal Votruba

53 2019 Independent Director